SCHEMBL3268743

SCHEMBL3268743

COc1ccc(F)cc1CNc1cc(N)c2cc(NCc3cccnc3)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 9/20 0.48
DHFR P00374 2/20 0.46
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 2/20 0.45
ALOX15 P16050 2/20 0.45
CYP2C19 P33261 2/20 0.45
HSD17B10 Q99714 2/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
PABPC1 P11940 1/20 0.43
PDE4B Q07343 1/20 0.43
KCNH2 Q12809 1/20 0.43
PGK1 P00558 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3268137 0.92 CYP1A2 (0.47) DHFRALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3267162 0.91 NTRK1 (0.52) NTRK1DHFRKCNH2
SCHEMBL3268552 0.85 CYP1A2 (0.50) NTRK1ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3268429 0.84 DHFR (0.50) NTRK1DHFRKCNH2
SCHEMBL3267094 0.83 CYP1A2 (0.47) NTRK1ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3267190 0.83 DHFR (0.50) DHFRALDH1A1MEN1KMT2A
SCHEMBL3267029 0.82 DHFR (0.52) NTRK1DHFRCYP1A2CYP3A4CYP2D6
SCHEMBL8509984 0.82 KCNH2 (0.49) NTRK1ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3271309 0.81 DHFR (0.53) DHFRALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3273200 0.81 ALDH1A1 (0.42) NTRK1DHFRALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399674-B2 Quinolines HOFFMAN-LA ROCHE INC. (US) 2013-03-19 US claimed
US-20120136018-A1 QUINOLINES KOLCZEWSKI SABINE (DE) 2012-05-31 US claimed
EP-2195296-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-06-16 EP claimed
US-20090088451-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 US claimed
WO-2009040290-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 WO claimed
US-8399674-B2 Quinolines HOFFMAN-LA ROCHE INC. (US) 2013-03-19 US disclosed
US-20120136018-A1 QUINOLINES KOLCZEWSKI SABINE (DE) 2012-05-31 US disclosed
EP-2195296-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-06-16 EP disclosed
US-20090088451-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 US disclosed
WO-2009040290-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088451-A1 QUINOLINES HTR5A, HTR1A, HTR1E NTRK1 529/4885DHFR 499/4885ALDH1A1 961/4885
US-20120136018-A1 QUINOLINES HTR5A, HTR1A, HTR1E NTRK1 529/4885DHFR 499/4885ALDH1A1 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.